Neoadjuvant Chemotherapy for Male Breast Cancer - “Pushing the Boundaries”

We report the case of a 67-year-old male with Grade III invasive ductal carcinoma and lymph node metastasis who underwent neoadjuvant chemotherapy prior to surgical treatment. In addition, we discuss the current rationale and evidence behind neoadjuvant chemotherapy for breast cancer, and the justification for providing this treatment in male breast cancer.Due to the rarity of male breast cancer, it is difficult to determine its optimal management, but it would appear reasonable to extrapolate from studies on the management of female breast cancer.

Source: Hellenic Journal of Surgery - February 28, 2019 Category: Surgery Source Type: research